Response of high-sensitivity C-reactive protein to percutaneous coronary intervention in patients with acute coronary syndrome

被引:0
|
作者
Kyeong Ho Yun
Myung Ho Jeong
Seok Kyu Oh
Sang Jae Rhee
Eun Mi Park
Eun Mi Lee
Nam Jin Yoo
Nam-Ho Kim
Young Keun Ahn
Jin-Won Jeong
机构
[1] Wonkwang University Hospital,Department of Cardiovascular Medicine
[2] Chonnam National University Hospital,Department of Cardiovascular Medicine
来源
Heart and Vessels | 2009年 / 24卷
关键词
Percutaneous coronary angioplasty; Stent; C-reactive protein; Inflammation;
D O I
暂无
中图分类号
学科分类号
摘要
Percutaneous coronary intervention (PCI) provokes an inflammatory reaction, as shown by increased concentrations of plasma C-reactive protein (CRP) after PCI. However, the changes of CRP levels after PCI in patients with acute coronary syndrome (ACS) have not been well evaluated. We evaluated the characteristics of the patients with elevated CRP response after PCI and whether an increase in CRP after PCI predicts long-term prognosis in patients with ACS. We studied consecutive 360 patients with ACS who underwent elective coronary stenting. Inflammatory response to PCI was calculated as the difference between the peak postprocedural hsCRP level and the preprocedural hsCRP level (ΔCRP). Twelve months follow-up data were obtained and clinical outcomes were compared with ΔCRP. In receiver operating characteristics analyses, the cutoff point of ΔCRP for major adverse cardiac events (MACE) was 3.0 mg/l, which yielded sensitivity of 61.7% and specificity of 69.7%. The patients with ΔCRP > 3 mg/l revealed higher incidence of myocardial infarction (37.7 vs 14.6%, P < 0.001), and ACC/AHA type B2/C lesion (81.5 vs 68.7%, P = 0.006) than in patients with low ΔCRP. White blood cell count, low-density lipoprotein cholesterol, peak creatinine kinase-MB, and peak troponin T were significantly elevated in patients with ΔCRP > 3 mg/l than in those with ≤3 mg/l. There was significant correlation between ΔCRP and the changes in troponin T after PCI (r = 0.210, P < 0.001). An increase in hsCRP > 3 mg/l after PCI had a higher predictive value for the occurrence of MACE than low hsCRP elevation (hazard ratio 2.1, P = 0.005). In multivariate analysis, ΔCRP and peak troponin T were independent predictors of MACE (P < 0.001 and P = 0.013, respectively). In conclusion, postprocedural hsCRP elevation >3 mg/l was associated with higher incidence of MACE in patients with ACS. ΔCRP determinations may be of value for risk stratification after PCI.
引用
收藏
页码:175 / 180
页数:5
相关论文
共 50 条
  • [21] Impact of the metabolic syndrome on high-sensitivity C reactive protein levels in patients with acute coronary syndrome
    Kilic, Teoman
    Jneid, Hani
    Ural, Ertan
    Oner, Gokhan
    Sahin, Tayfun
    Kozdag, Guliz
    Kahraman, Goksel
    Ural, Dilek
    ATHEROSCLEROSIS, 2009, 207 (02) : 591 - 596
  • [22] High high-sensitivity C-reactive protein/BMI ratio predicts future adverse outcomes in patients with acute coronary syndrome
    Jia, Lei
    Yuan, Jin-Qing
    Zhu, Ling
    Zhang, Yin
    CORONARY ARTERY DISEASE, 2019, 30 (06) : 448 - 454
  • [23] Relationship Between Coronary Arterial Remodeling, Fibrous Cap Thickness and High-Sensitivity C-Reactive Protein Levels in Patients With Acute Coronary Syndrome
    Kashiwagi, Manabu
    Tanaka, Atsushi
    Kitabata, Hironori
    Tsujioka, Hiroto
    Matsumoto, Hiroki
    Arita, Yu
    Ookochi, Keishi
    Kuroi, Akio
    Kataiwa, Hideaki
    Tanimoto, Takashi
    Ikejima, Hideyuki
    Takarada, Shigeho
    Kubo, Takashi
    Hirata, Kumiko
    Nakamura, Nobuo
    Mizukoshi, Masato
    Imanishi, Toshio
    Akasaka, Takashi
    CIRCULATION JOURNAL, 2009, 73 (07) : 1291 - 1295
  • [24] High-sensitivity C-reactive protein predicts 10-year cardiovascular outcome after percutaneous coronary intervention
    Oemrawsingh, Rohit M.
    Cheng, Jin M.
    Akkerhuis, K. Martijn
    Kardys, Isabella
    Degertekin, Muzaffer
    van Geuns, Robert-Jan
    Daemen, Joost
    Boersma, Eric
    Serruys, Patrick W.
    van Domburg, Ron T.
    EUROINTERVENTION, 2016, 12 (03) : 345 - 351
  • [25] High-sensitivity C-reactive protein in the prediction of coronary events in patients with premature coronary artery disease
    Speidl, WS
    Graf, S
    Hornykewycz, S
    Nikfardjam, M
    Niessner, A
    Zorn, G
    Wojta, J
    Huber, K
    AMERICAN HEART JOURNAL, 2002, 144 (03) : 449 - 455
  • [26] In-Stent Restenosis, the Achilles' Heel of Percutaneous Coronary Intervention: The Predictive Role of High-Sensitivity C-Reactive Protein
    Ibrahim, Akram W.
    CARDIOVASCULAR REVASCULARIZATION MEDICINE, 2019, 20 (07) : 542 - 543
  • [27] High-sensitivity C-reactive protein predicts contrast-induced nephropathy after primary percutaneous coronary intervention
    Liu, Yong
    Tan, Ning
    Zhou, Ying-Ling
    Chen, Yu-Yi
    Chen, Ji-Yan
    Chen, Jin
    Luo, Jian-Fang
    JOURNAL OF NEPHROLOGY, 2012, 25 (03) : 332 - 340
  • [28] Long-Term Predictive Value of High-Sensitivity C-Reactive Protein for Cancer Mortality in Patients Undergoing Percutaneous Coronary Intervention
    Endo, Hirohisa
    Dohi, Tomotaka
    Funamizu, Takehiro
    Shitara, Jun
    Wada, Hideki
    Doi, Shinichiro
    Naito, Ryo
    Konishi, Hirokazu
    Ogita, Manabu
    Iwata, Hiroshi
    Kasai, Takatoshi
    Okazaki, Shinya
    Isoda, Kikuo
    Shimada, Kazunori
    Miyauchi, Katsumi
    Daida, Hiroyuki
    CIRCULATION JOURNAL, 2019, 83 (03) : 630 - +
  • [29] Impact of Preprocedural High-Sensitivity C-Reactive Protein on Contrast-Induced Nephropathy in Patients Undergoing Primary Percutaneous Coronary Intervention
    Zhang Jian-Wei
    Zhou Yu-Jie
    Cao Shu-Jun
    Yang Qing
    Yang Shi-Wei
    Nie Bin
    ANGIOLOGY, 2014, 65 (05) : 402 - 407
  • [30] The Effect of Different NLRP3 Inflammasome Inhibitors on High-Sensitivity C-reactive Protein in Patients After Percutaneous Coronary Intervention
    Yu, Miao
    Zhu, Zheng-Feng
    Yang, Fen
    Yuan, Yuan-Fan
    Liao, Shu-De
    Liu, Mei-Lin
    Cheng, Xiang
    CIRCULATION, 2023, 148